Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for brain injury
IRCT20081208001497N8Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in traumatic brain injury (TBI) comparing Melatonin with Placebo (2 arms). Primary endpoints: S100beta, Malondialdehyde and 6 more. Started Apr 2019; status: completed.
02
Drugs
melatonin
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on IRCT20081208001497N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20081208001497N8.